NDC 62756-060
epoprostenol
Epoprostenol
epoprostenol is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is Epoprostenol Sodium.
| Product ID | 62756-060_4a908d55-af35-4d85-b188-37a7ffad2e71 |
| NDC | 62756-060 |
| Product Type | Human Prescription Drug |
| Proprietary Name | epoprostenol |
| Generic Name | Epoprostenol |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-01-16 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA210473 |
| Labeler Name | Sun Pharmaceutical Industries, Inc. |
| Substance Name | EPOPROSTENOL SODIUM |
| Active Ingredient Strength | 2 mg/10mL |
| Pharm Classes | Prostacycline Vasodilator [EPC],Prostaglandins I [CS],Vasodilation [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |